These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 17389010

  • 1. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C, Morales LD, Cruz MA.
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
    Nishio K, Anderson PJ, Zheng XL, Sadler JE.
    Proc Natl Acad Sci U S A; 2004 Jul 20; 101(29):10578-83. PubMed ID: 15249683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S, Li CQ, Cao Z, Wang H, Wardell MR, Sadler JE.
    J Biol Chem; 2000 Mar 17; 275(11):7539-46. PubMed ID: 10713059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.
    Parker DN, Tasneem S, Farndale RW, Bihan D, Sadler JE, Sebastian S, de Groot PG, Hayward CP.
    Thromb Haemost; 2016 Jul 04; 116(1):87-95. PubMed ID: 27052467
    [Abstract] [Full Text] [Related]

  • 11. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A, Yamamoto H, Thys C, Kito M, Vermylen J, Hoylaerts MF.
    Blood; 2003 Feb 15; 101(4):1375-83. PubMed ID: 12393553
    [Abstract] [Full Text] [Related]

  • 12. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
    Ulrichts H, Udvardy M, Lenting PJ, Pareyn I, Vandeputte N, Vanhoorelbeke K, Deckmyn H.
    J Biol Chem; 2006 Feb 24; 281(8):4699-707. PubMed ID: 16373331
    [Abstract] [Full Text] [Related]

  • 13. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A, Ribba AS, Lavergne JM, Fressinaud E, Juhan-Vague I, Mazurier C, Girma JP, Meyer D.
    Br J Haematol; 2003 Feb 24; 120(4):643-51. PubMed ID: 12588351
    [Abstract] [Full Text] [Related]

  • 14. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.
    Morales LD, Martin C, Cruz MA.
    J Thromb Haemost; 2006 Feb 24; 4(2):417-25. PubMed ID: 16420575
    [Abstract] [Full Text] [Related]

  • 15. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA, Mancuso DJ, Evan Sadler J, Ponder JW, Jozwiak MA, Christopherson PA, Cox Gill J, Paul Scott J, Montgomery RR.
    Blood; 1998 Mar 01; 91(5):1572-81. PubMed ID: 9473222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
    Madabhushi SR, Zhang C, Kelkar A, Dayananda KM, Neelamegham S.
    J Am Heart Assoc; 2014 Oct 23; 3(5):e001420. PubMed ID: 25341886
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.
    Chen J, Ling M, Fu X, López JA, Chung DW.
    Arterioscler Thromb Vasc Biol; 2012 Nov 23; 32(11):2625-30. PubMed ID: 22922961
    [Abstract] [Full Text] [Related]

  • 19. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M, Facey DA, Favaloro EJ, Hertzberg MS, Whisstock JC, McNally T, Andrews RK, Berndt MC.
    Blood; 2000 Jan 01; 95(1):164-72. PubMed ID: 10607699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.